H.R. 1409 · 115th Congress · 2017–2018
Cancer Drug Parity Act of 2017
H.R. 1409 in the 115th Congress (2017–2018) was introduced on Mar 7, 2017, sponsored by Leonard Lance with 175 co-sponsors.
During the 115th Congress (2017–2018), Donald Trump was president, and Republicans held majorities in both the House and Senate.
- Status
- Introduced
- Introduced
- Mar 7, 2017
- Co-sponsors
- 175
- Policy area
- Health
What it does
Cancer Drug Coverage Act of 2017 This bill amends the Public Health Service Act to require group and individual health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications.
Summary by the nonpartisan Congressional Research Service.
Sponsor
Leonard Lance (R-NJ). Co-sponsors: 90 Democrats, 85 Republicans.
Where it stands
- IntroducedMar 7, 2017
- Passed the House—
- Passed the Senate—
- Sent to the President—
- Became law—
Latest action: Referred to the Subcommittee on Health. (Mar 17, 2017)
More bills from Leonard Lance in the 115th Congress
Other Health bills in the 115th Congress
- H.J.Res. 43: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the…
- H.R. 2430: FDA Reauthorization Act of 2017
- S. 652: Early Hearing Detection and Intervention Act of 2017
- S. 920: National Clinical Care Commission Act
- H.R. 304: Protecting Patient Access to Emergency Medications Act of 2017
- H.R. 4374: To amend the Federal Food, Drug, and Cosmetic Act to authorize additional emergency uses for…
- H.R. 3759: RAISE Family Caregivers Act
- S. 204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
- S. 292: Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018
- H.R. 931: Firefighter Cancer Registry Act of 2018
Committees
More
From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.
Cite or embed this page
Capitol Receipts, “H.R. 1409 (115th Congress): Cancer Drug Parity Act of 2017,” https://www.capitolreceipts.com/bill/115-hr-1409/cancer-drug-parity-act-of-2017 (accessed 2026-10-17).